BioCentury
ARTICLE | Clinical News

FDA accepts NDA for Kitov's KIT-302 to treat OA pain and hypertension

November 30, 2017 11:20 PM UTC

FDA accepted for review an NDA from Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV) for celecoxib/amlodipine besylate (KIT-302) to treat pain associated with osteoarthritis and hypertension simultaneously. The PDUFA date is May 31...

BCIQ Company Profiles

Purple Biotech Ltd.